Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04079738
Title Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors H Scott Boswell
Indications

acute myeloid leukemia

Therapies

Ixazomib + Mivavotinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis Indiana 46202 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field